Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol.

about

A comparison of four methods for the analysis of N-of-1 trials The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Use of omalizumab in a severe asthma clinic.

P2860

Q28539492-D0552356-F314-4BE5-8A36-0B7C392C0905 Q37892929-CD0E391A-D3C6-4872-97ED-53B47E679474 Q53165967-8CDCB509-02BC-4150-9397-56B719ED8344

P2860

Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol.

Item

http://www.wikidata.org/entity/Q46797788

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Eformoterol n-of-1 trials in c ...... orly reversible to salbutamol.

@en

Eformoterol n-of-1 trials in c ...... orly reversible to salbutamol.

@nl

type

Item

label

Eformoterol n-of-1 trials in c ...... orly reversible to salbutamol.

@en

Eformoterol n-of-1 trials in c ...... orly reversible to salbutamol.

@nl

prefLabel

Eformoterol n-of-1 trials in c ...... orly reversible to salbutamol.

@en

Eformoterol n-of-1 trials in c ...... orly reversible to salbutamol.

@nl

P1476

Eformoterol n-of-1 trials in c ...... orly reversible to salbutamol.

@en

P2093

A J Veale

http://www.w3.org/2001/XMLSchema#string

B J Smith

http://www.w3.org/2001/XMLSchema#string

D Veljkovic

http://www.w3.org/2001/XMLSchema#string

H J McElroy

http://www.w3.org/2001/XMLSchema#string

L Saccoia

http://www.w3.org/2001/XMLSchema#string

P2860

Health status measurement in chronic obstructive pulmonary disease.

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease

Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.

Caring for elderly dependents: effects on the carers' quality of life.

A measure of quality of life for clinical trials in chronic lung disease

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.

P304

63-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/1479972304CD028OA

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sarah Appleton

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16279260

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

salbutamol

Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol.

about

P2860

P2860

Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921